Replies to post #44 on Zosano Pharma Corp. (fka ZSANQ)

[BelizeBeachTrader]

ZSAN is using already approved migraine medication in the Phase 3 trial. The trial is to show the ability to transfer the medication at close to same rate as a injection.
They have already done this on healthy subjects in P1 trial. That why no P2 and have gone right to P3.
quote:
"ZP-Triptan demonstrated rapid absorption compared to the zolmitriptan tablet."
http://ir.zosanopharma.com/releasedetail.cfm?ReleaseID=939871

Now its just to prove that rapid absorption of the current treatment produces rapid relief.
As you stated ZSAN has already demonstrated this in the other two completed P2's for other indications.

Very good odds that the migraine P3 will be a success.
I added more today.